Bob is a sales guy ....... and that's good when we want to market the company, however not that good when we need to complete a clinical trial in covid ..... he has made a bunch of errors ..... poor timing of credit raising in the past , poor approach to a Clincial trial patient ...... good salesman and a good presenter ...... but we need results delivered ..... let's hope Bob can get it right for 2022
IBX Price at posting:
9.9¢ Sentiment: Hold Disclosure: Held
